{
    "type": "ETC",
    "leverage": true,
    "derivatives": true,
    "swaps": true,
    "inverse": true,
    "replication_method": "synthetic",
    "ucits": false,
    "complex_factors": [
        "Leverage",
        "Inverse Exposure",
        "Daily Compounding",
        "Futures Rolling",
        "High Volatility Risk"
    ],
    "classification": "complex",
    "supporting_data": "The WisdomTree Natural Gas 3x Daily Short ETC exhibits multiple complexity indicators under MiFID II. It provides -3x daily leveraged inverse exposure to natural gas futures, which introduces significant complexity due to daily compounding effects and the potential for amplified losses. The product uses synthetic replication via swaps, as confirmed in the factsheet ('Fully Collaterised Swap'), exposing investors to counterparty risk. The high risk rating of 7/7, the warning that it 'may be difficult to understand,' and the explicit statement that it is not suitable for retail investors without specific knowledge further support the complex classification. The product's reliance on futures rolling and the potential for tracking error due to contango/backwardation effects add additional layers of complexity. While the ETC is fully collateralized, the combination of leverage, inverse exposure, and synthetic replication makes it inherently complex under MiFID II standards.",
    "confidence": 95,
    "risk_level": 7,
    "counterparty_risk": true,
    "compounding_effect": true,
    "futures_rolling": true,
    "high_volatility": true,
    "intended_investor": "informed retail investors with specific knowledge",
    "recommended_holding_period": "1 day",
    "capital_protection": false,
    "currency_risk": true,
    "liquidity_risk": true,
    "market_risk": true,
    "credit_risk": true,
    "legal_risk": true,
    "regulatory_risk": true,
    "exchange_rate_risk": true,
    "interest_rate_risk": true,
    "inflationary_risk": true,
    "collateral_management": true,
    "tracking_error_risk": true,
    "comprehension_warning": true,
    "non_ucits": true,
    "daily_rebalancing": true,
    "amplified_losses": true,
    "short_term_investment": true,
    "sophisticated_investor_requirement": true,
    "additional_disclosures": "The product's prospectus and KIID emphasize the need for investors to understand daily rebalancing, compounding effects, and the risks of leveraged inverse exposure. The high transaction costs (3.58% per year) and the potential for significant deviation from the expected leveraged return over longer holding periods further justify the complex classification."
}